New drug duo aims to deepen leukemia remission
NCT ID NCT07271667
First seen Jan 05, 2026 · Last updated Jun 12, 2026 · Updated 21 times
Summary
This study tests whether adding emavusertib to a standard targeted therapy (zanubrutinib) can improve outcomes for people with chronic lymphocytic leukemia (CLL) and other B-cell cancers. About 108 adults with CLL who have already received some treatment will take both drugs. The goal is to see if the combination can make cancer undetectable or shrink tumors, but ongoing medication is expected.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC LYMPHOCYTIC LEUKEMIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Azienda Ospedale Università Padova
RECRUITINGPadova, 35128, Italy
-
Azienda Ospedaliero Universitaria Maggiore Della Carità
RECRUITINGNovara, 28100, Italy
-
Hospital Universitario Fundación Jiménez Díaz - START MADRID
RECRUITINGMadrid, 28040, Spain
-
IRCCS Ospedale San Raffaele
RECRUITINGMilan, 20132, Italy
-
MD Anderson Cancer Center Madrid
RECRUITINGMadrid, 28033, Spain
-
Mayo Clinic
RECRUITINGRochester, Minnesota, 55905, United States
-
Mt Sinai Comprehensive Cancer Center
RECRUITINGMiami Beach, Florida, 33140, United States
-
Ohio State University Comprehensive Cancer Center
RECRUITINGColumbus, Ohio, 43210, United States
-
Summit Medical Group
RECRUITINGFlorham Park, New Jersey, 07932, United States
-
Texas Oncology - Sammons Cancer Center
RECRUITINGDallas, Texas, 75246, United States
-
UPMC Hillman Cancer Center
RECRUITINGPittsburgh, Pennsylvania, 15232, United States
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.